Tauriga Sciences Now Pre-Selling Rainbow Deluxe Sampler Pack

Tauriga Sciences-logo-CBD-CBDToday
Logo: Tauriga Sciences

NEW YORK – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that it is now Pre-Selling its propriety Rainbow Deluxe Sampler Pack (“Rainbow Pack”) exclusively on its E-Commerce Website (www.taurigum.com). The Company has assembled a multi-faceted and diverse marketing initiative to support the upcoming – Official Launch – of this important new product offering. Each Rainbow Pack carries an MSRP of $99.99 and there will be a special packaging component for customers to enjoy.

Link: https://taurigum.com/products/rainbow-deluxe-sampler-pack

Advertisement
gnln.com

The Official Rainbow PackProduct Launch is expected to commence during the first two weeks of August 2020.

Separately, the Company is planning to issue a press release on Monday August 3, 2020 to disclose the performance of its highest margin E-Commerce business segment – for the Month of July 2020. The Company continues to experience impressive levels of growth and overall strength – with respect to this most important business segment.


ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™️, consists of a proprietary supplement chewing gum that is both Kosher certified and Vegan formulated (CBD Infused Tauri-Gum™️ Flavors: Mint, Blood Orange, Pomegranate) & (CBG Infused Tauri-Gum™️ Flavor: Peach-Lemon). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at www.tauriga.com
Complementary to the Company’s retail business, are its two ongoing biotechnology initiatives. The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™️, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™️. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.
The Company is headquartered in New York City and operates a regional office in Barcelona, Spain. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.

Advertisement
kushycbd.com